Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2018

View Archived Issues

Positive data presented from SEQUOIA and CEDAR phase III studies of abicipar

Transgenic mouse model useful to study the hypersensitivity reactions of abacavir

Phase IIa study of BT-063 for the treatment of SLE meets primary endpoint

Gritstone Oncology to test GRANITE-001 with Opdivo and Yervoy

Membrane findings point to new antimalarial strategies

Sending live phages after deadly lung infections

The Yang to KRAS' Yin?

First biomarker for liver injury from biologic

AT: all bad for platelets

Aevi presents AEVI-004, novel co-crystal version of AEVI-001

UCT-943, a next-generation PI4K inhibitor antimalarial agent: Preclinical profile

Wakamoto completes phase II trial of WP-1303

BeiGene reports preliminary phase II topline data for tislelizumab in classical Hodgkin's lymphoma

FDA grants approval to Tibsovo for relapsed/refractory AML with IDH1 mutation

UCB Pharma divulges UDP/CysLT receptor modulators

Researchers find IL-6 levels tied to worse prognosis in ESCC patients

New G protein-coupled receptor 39 agonists patented by Daiichi Sankyo

INSERM and collaborators describe lactic acid bacteria compositions

Samsung Life Public Welfare Foundation creates siRNAs specific to the SS18-SSX fusion gene

ShanghaiTech University synthesizes PIWIL4 inhibitors

New phase I study evaluates MK-4830 alone and with pembrolizumab for advanced solid tumors

FDA approves single-dose Krintafel for radical cure of P. vivax malaria

Asceneuron presents phase I results for ASN-120290

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...